These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11092203)

  • 1. Vascular function in systemic sclerosis.
    Herrick AL
    Curr Opin Rheumatol; 2000 Nov; 12(6):527-33. PubMed ID: 11092203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic sclerosis induces pronounced peripheral vascular dysfunction characterized by blunted peripheral vasoreactivity and endothelial dysfunction.
    Frech T; Walker AE; Barrett-O'Keefe Z; Hopkins PN; Richardson RS; Wray DW; Donato AJ
    Clin Rheumatol; 2015 May; 34(5):905-13. PubMed ID: 25511849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Raynaud phenomenon and scleroderma].
    Haustein UF
    Hautarzt; 1996 May; 47(5):336-40. PubMed ID: 8707577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Aspects in the Pathophysiology of Peripheral Vasculopathy in Systemic Sclerosis.
    Suliman YA; Distler O
    Curr Rheumatol Rev; 2013; 9(4):237-44. PubMed ID: 26932287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis.
    Sfikakis PP; Papamichael C; Stamatelopoulos KS; Tousoulis D; Fragiadaki KG; Katsichti P; Stefanadis C; Mavrikakis M
    Arthritis Rheum; 2007 Jun; 56(6):1985-93. PubMed ID: 17530638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new avenue in the pathogenesis of systemic sclerosis: the molecular interface between the endothelial and the nervous systems.
    Romano E; Rosa I; Fioretto BS; Guiducci S; Manetti M; Matucci-Cerinic M
    Clin Exp Rheumatol; 2019; 37 Suppl 119(4):133-140. PubMed ID: 31025932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology and clinical consequences of Raynaud's phenomenon related to systemic sclerosis.
    Sunderkötter C; Riemekasten G
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii33-5. PubMed ID: 16987831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of vascular disease biomarkers for digital ulcers in systemic sclerosis patients.
    Silva I; Teixeira A; Oliveira J; Almeida I; Almeida R; Vasconcelos C
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S127-30. PubMed ID: 26242908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective endothelially mediated pulmonary vasodilation in systemic sclerosis.
    Cailes J; Winter S; du Bois RM; Evans TW
    Chest; 1998 Jul; 114(1):178-84. PubMed ID: 9674467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular abnormalities in scleroderma.
    Herron GS; Romero LI
    Semin Cutan Med Surg; 1998 Mar; 17(1):12-7. PubMed ID: 9512101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two faces of the same coin: Raynaud phenomenon and digital ulcers in systemic sclerosis.
    Galluccio F; Matucci-Cerinic M
    Autoimmun Rev; 2011 Mar; 10(5):241-3. PubMed ID: 20863907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The loss of endothelium-dependent vascular tone control in systemic sclerosis.
    Livi R; Teghini L; Generini S; Matucci-Cerinic M
    Chest; 2001 Feb; 119(2):672-3. PubMed ID: 11171770
    [No Abstract]   [Full Text] [Related]  

  • 13. Endothelial dysfunction in systemic sclerosis.
    Altorok N; Wang Y; Kahaleh B
    Curr Opin Rheumatol; 2014 Nov; 26(6):615-20. PubMed ID: 25191994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raynaud's phenomenon and vascular disease in systemic sclerosis.
    Generini S; Matucci Cerinic M
    Adv Exp Med Biol; 1999; 455():93-100. PubMed ID: 10599328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral arterial stiffness and endothelial dysfunction in idiopathic and scleroderma associated pulmonary arterial hypertension.
    Peled N; Shitrit D; Fox BD; Shlomi D; Amital A; Bendayan D; Kramer MR
    J Rheumatol; 2009 May; 36(5):970-5. PubMed ID: 19369472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved endothelial function after endothelin receptor blockade in patients with systemic sclerosis.
    Cardillo C; Schinzari F; Melina D; Mores N; Bosello S; Peluso G; Zoli A; Ferraccioli G
    Arthritis Rheum; 2009 Jun; 60(6):1840-4. PubMed ID: 19479828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial dysfunction is present only in the microvasculature and microcirculation of early diffuse systemic sclerosis patients.
    Domsic RT; Dezfulian C; Shoushtari A; Ivanco D; Kenny E; Kwoh CK; Medsger TA; Champion HC
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-154-60. PubMed ID: 25372799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital iontophoresis of vasoactive substances as measured by laser Doppler imaging--a non-invasive technique by which to measure microvascular dysfunction in Raynaud's phenomenon.
    Anderson ME; Moore TL; Lunt M; Herrick AL
    Rheumatology (Oxford); 2004 Aug; 43(8):986-91. PubMed ID: 15199217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maximum blood flow and microvascular regulatory responses in systemic sclerosis.
    Gunawardena H; Harris ND; Carmichael C; McHugh NJ
    Rheumatology (Oxford); 2007 Jul; 46(7):1079-82. PubMed ID: 17494087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between left ventricular myocardial involvement and endothelial dysfunction in systemic sclerosis: noninvasive assessment in asymptomatic patients.
    D'Andrea A; Stisi S; Caso P; Uccio FS; Bellissimo S; Salerno G; Scarafile R; Riegler L; Cuomo S; Citro R; Scherillo M; Calabrò R
    Echocardiography; 2007 Jul; 24(6):587-97. PubMed ID: 17584198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.